Genomenon, Inc.
Public SEC Form D filing history for Genomenon, Inc., scored as a sales-ready lead.
| Score | Company | Industry | Raise | Filed |
|---|---|---|---|---|
| 82 | Genomenon, Inc. | Biotechnology | $6,025,002 | 2026-07-30 |
Executives & directors
Self-disclosed on the company's own SEC Form D filing (Item 3).
- Michael Klein — Executive Officer, Director
- Mark Kiel — Executive Officer, Director
- Patricia Glaza — Director
- David Gregorka — Director
- Michael Gross — Director
- Brian Groark — Executive Officer
- Sam Globus — Executive Officer
Want to know the moment a company like Genomenon, Inc. files, not weeks later? Free API key, no card required.
See pricing & get a free key